Abstract
BackgroundFour new disease specific composite disease activity measures have been developed for psoriatic arthritis (PsA). Further validation of these measures in interventional trial data is now required.ObjectivesThe objective of this...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
